Gene profiling of Japanese medaka (Oryzias latipes) was performed using an oligonucleotide DNA microarray representing 22,587 TIGR O. latipes gene indices (OLGIs). The average correlation coefficients for gene expression between individual mature fish were high (>0.95) for both female and male, indicating that the physiological status of medaka is highly reproducible under prescribed growth conditions. Of the 22,587 OLGIs, 2575 showed significant differences in expression between female and male. Exposure to 17β-estradiol (E2) revealed 381 E2-responsive OLGIs in male medaka. Feminization and male-dysfunction factors of the E2-treated males calculated using the combination of Pearson correlation coefficient and Euclidean distances indicate that E2 treatment "weakly feminized" male medaka, while male physiological functions were not significantly disrupted. This study demonstrates the possibility of using medaka microarrays to estimate the overall effects of hormonally active chemicals.
Approximately 25 million chemicals are listed in Chemical Abstracts (http://www.cas.org/cgi-bin/regreport.pl). It has been proposed that tens of thousands of chemicals are discharged into and presumably accumulate in our environment. Among these, chemicals termed environmental pollutants can function directly as toxins to various organisms or indirectly as modifiers of normal biochemical processes. For example, there is a growing concern that certain chemicals, termed endocrine disruptors, may change the reproductive status of organisms by adversely affecting endocrine systems [1] .
Technological advances in analytical techniques have given researchers the ability to detect lower concentrations of chemicals in animal tissues, surface water, sediments, and air. However, the concentrations of chemicals, especially in complex mixtures, do not correlate well with the degree of toxicity to organisms. To address this problem, a variety of bioassays and biomarkers have been developed to evaluate the effects of a chemical on the survival, development, growth, reproduction, and physiology of various organisms [2, 3] . Molecular and biochemical techniques have also been used to investigate toxicity and elucidate chemical toxicity mechanisms. Nonetheless, classical toxicological methods, which measure a limited number of endpoints, often cannot provide adequate insight into the mechanisms behind complex modes of toxicity and generally offer limited predictive value in longterm risk assessment for clinical trials. Thus, there is clearly a need for development of more effective preclinical and/or clinical screens for examining the toxic effects of chemicals.
Since changes in the patterns of gene expression within a living cell can reflect changes in the physiological state, detection of perturbations in gene expression should allow the evaluation of multiple types of toxicity, from acute toxicity to endocrine disruption. Toxicogenomics, the use of comprehensive gene expression changes to evaluate chemical toxicity, greatly expands the scope and depth of this approach in toxicology [4] . Toxicogenomic gene expression studies have been facilitated by the development of microarray technologies.
The advent of DNA microarrays in the mid-1990s [5, 6] provided a means for analyzing the expression of thousands of genes simultaneously. This advantage allows toxicologists to take a whole-organism perspective on toxicity, in that the effects of a substance on the expression of virtually all known genes can be assessed within a single microarray [4] . DNA microarray can also be used to assess physiological reproducibility: Since mRNA expression profiles reflect an organism's physiology, the ability to measure accurately changes in mRNA expression levels promises high reproducibility between biological experiments.
The Japanese medaka (Oryzias latipes), selected by the Japanese Ministry of the Environment as an indicator species for ecotoxicological study, has been a focus species in bioassay research. Standardized procedures for medaka bioassays are recommended and published by the Japanese Ministry of the Environment (http://www.env.go.jp/chemi/kagaku/). The applicability, precision, and reproducibility of these procedures, which are based primarily on methods developed by scientists studying medaka, need to be evaluated and standardized to obtain reproducible and comparable experimental results within the medaka research community.
Medaka is also widely accepted as an experimental model system for development, histology, and sexual differentiation research. Like many other fish, the sex of medaka is XX/XY coded and can be easily distinguished by external sex characteristics [7] . Detailed characterizations of gonadal differentiation and morphology are available to serve as the standard for detecting aberrant histopathological effects [8] . Interestingly, the sex of medaka can be functionally reversed if androgens or estrogens are applied during a sensitive period of embryonic or juvenile development [7, 9] . In addition, cDNAs of sex-specific genes like vitellogenin [10] and choriogenin H [11] have been cloned and sequenced and can be used to analyze sex-specific gene expression. The Y-chromosome-linked sexdetermination gene DMY of medaka was recently identified, the first example among teleost fish [12] . Large-scale gene expression analyses have been applied to medaka developmental biology [13, 14] . These experimental resources and devel-opmental features make medaka an ideal vertebrate animal model to study the effects of chemicals on sexual differentiation and development.
The objective of this study was to test the efficacy of medaka bioassay standard procedures using an oligonucleotide-based medaka DNA microarray containing 22,587 probes. Our previous studies using yeast cDNA microarrays had shown high correlation coefficients of gene expression among independently cultured cells [15] . Therefore, we first confirmed the high correlation coefficients of gene expression in individual medaka grown under the standard procedures. Second, we exposed male medaka to 17β-estradiol (E2), a female sex steroid hormone, and assessed E2-induced changes in mRNA expression with a medaka DNA oligonucleotide microarray. Furthermore, to identify the genes responsible for feminization of male fish by estrogenic chemicals, changes in the mRNA expression profile of the E2-exposed fish were compared with the normal patterns of sex-specific gene expression in medaka. Based on the mRNA expression profiles, assessment of the degree of feminization/demasculinization using the combination of Pearson correlation coefficient and Euclidean distances was attempted to estimate the impact of hormonally active chemicals, such as E2.
Results

Physiological reproducibility of standard procedure
The medaka array contained 22,587 TIGR (The Institute for Genomic Research) O. latipes (Japanese medaka) gene indices (OLGIs) [10,085 TCs (tentative consensuses), 12,333 singleton ESTs (expressed sequence tags), and 169 singleton ETs (expressed transcripts)], with four probes for each OLGI. The expression level of each OLGI was defined as the average of the signal intensities from the four probes hybridized to the OLGI. With this microarray, we looked for differences in gene expression between individual male and female fish ( Fig. 1 ). As mentioned in the introduction, male and female fish are distinguishable by external secondary characteristics [7] : Male dorsal and anal fin rays are longer and thicker than those of the females and have a characteristic notch at the posterior of the Fig. 1 . Scatter plots of medaka microarray analyses of mRNA expression: male 2 vs male 1 (left), female 2 vs female 1 (center), and female 1 vs male 1 (right). saw-toothed distal margin. In the mature female, the urogenital papilla is a paired protuberance between the anus and the oviduct opening. Alternatively, males feature a single-lobed prominence between the anus and the urogenitals. Correlation coefficients of gene expression patterns among male and among female fish are shown in Table 1 . Brood stock specimens consisted of three male and three female fishes. An additional three different male samples were used as the untreated controls in the E2 exposure experiment. The correlation coefficient values were >0.96 among female fish, whereas those values varied from 0.88 to 0.99 among male fish ( Table 1 ). The average of correlation coefficients among male and female medaka were high [0.956 (n = 6) for male and 0.969 (n = 3) for female], indicating that variances between medaka mRNA expression profiles were small. This result implies that highly reproducible physiological data can be obtained from medaka maintained under the standard conditions ( [2] ; http://www.env. go.jp/chemi/kagaku/).
Differential expression profiles between male and female
In contrast to the high correlation coefficients among the male-male or the female-female comparisons, correlation coefficients in gene expression between individual males and females were lower ( Fig. 1 , Table 1 ). The mean of correlation coefficients between individual males and females was 0.891. Among the 22,587 OLGIs analyzed, we identified OLGIs corresponding to genes preferentially expressed in either male or female using an analysis of variance analysis (ANOVA). In the comparisons of gene expression between male and female, OLGIs that gave p values less than 0.05 were considered markers for male-or female-specific genes. By this criterion, 1844 OLGIs were estimated to represent genes specifically expressed in the female, and 731 represented male-specific genes. The female-specific OLGIs represented sequences of previously characterized female-specific genes such as vitellogenin I/II, choriogenin H/L, ZP family genes (ZPA, ZPB, and ZPC), cyclins B, FIGα, and 42Sp50 [16] (see Supplementary  Table 1 ; it should be noted that in this report, the TC numbers and tentative annotations in all supplementary tables are derived from TIGR database release 4.0). Unlike the female-specific OLGIs, most of the male-specific OLGIs have not yet been assigned or characterized (see Supplementary Table 2 ).
Nonetheless, these OLGIs are good candidates for male-specific biomarkers. These results suggest that medaka microarrays can be used to distinguish physiological sex by analyzing the expression profiles of sex-specific OLGIs.
17β-Estradiol-responsive genes
It has been previously demonstrated that E2 treatment causes feminization (e.g., formation of oocytes in the testis, known as testis-ova, and vitellogenin induction) of male medaka [17, 18] . To identify changes in gene expression in response to E2, mature male medaka were exposed to 100 ng/L E2 for 21 days (conditions standardized by Japanese Ministry of the Environment for the vitellogenin induction assay; http://www.env.go.jp/ chemi/end/pdfs/emedaka_all.pdf), and cDNA prepared from E2-treated male medaka was applied to the microarrays. The average correlation coefficient among three E2-treated male medaka microarrays was 0.980 (data not shown), again demonstrating the reproducibility of mRNA expression profiles. In comparisons between the gene expression levels of six control males and three E2-treated males, we determined that E2 treatment resulted in significant changes (p < 0.05) in the signal intensities of 381 OLGIs: signal intensities from 242 OLGIs increased and from 139 OLGIs decreased. In general, E2dependent changes in gene expression were more extreme among those sequences showing increased expression in treated males, relative to sequences showing decreased expression. Among the 242 up-regulated sequences, 169 were also highly expressed in females ( Fig. 2, (a) , Supplementary Table 3) , whereas expression of the other 73 sequences was not statistically different between female and male medaka ( Fig.  2 , (e), Supplementary Table 4 ). The expression levels of vitellogenins and choriogenins were extremely high in both female and E2-treated male medaka (see Supplementary Tables  1 and 3) , whereas the expression levels of some oocyte-specific genes (e.g., ZP family, cyclins B, FIGα, and 42Sp50) were not significantly changed by E2 treatment (data not shown). Ninetyone of the 139 OLGIs representing genes down-regulated by E2 treatment of males were also expressed at low levels in the females ( Fig. 2 , (b), Supplementary Table 5 ), whereas 48 were down-regulated only in the E2-treated males ( Fig. 2 , (f), see also Supplementary Table 6 ). To visualize the OLGIs that were impacted the most, representative gene expression that was changed during feminization or unchanged by E2 treatment is shown in Fig. 3 .
Validation of changed gene expression by reverse transcription polymerase chain reaction (RT-PCR)
To test whether the changes in gene expression seen with the medaka microarray were reproducible by other methods, 30 OLGI sequences were selected for RT-PCR evaluation, so that the dataset would span the entire range of the gene expression ratios in the microarray. PCR primers for these genes were designed to be analogous to the sequences of the medaka microarray probes ( Table 2 ). The same RNA samples used for microarray analysis of females, males, and E2-treated males were used as templates for RT-PCR. Of the 30 OLGIs, valid quantitative PCR data could not be obtained from one OLGI, since it generated multiple products. As shown in Fig. 4 , inductions and suppressions were in line with the microarray data. This means that a good correlation was obtained between the expression levels measured by microarray and RT-PCR experiments.
Discussion
Bioassays and biomarkers have been employed to investigate the toxic effects of chemicals on a variety of test organisms [2, 3] . One of the test organisms, Japanese medaka, has been an excellent model for various studies, from mode-of-action investigations of particular toxins to studies involving assessments of sex differentiation, development, and histology [7] [8] [9] 12, 19] . Tremendous resources committed to the isolation and sequencing of medaka ESTs promise greater understanding within the field of medaka developmental biology [13, 14] . Using the Maskless Array Synthesizer (MAS) developed by Singh-Gasson et al. [20] , a medaka oligonucleotide microarray with 179,972 features that represent 22,587 OLGIs was recently [20] . Our primary goal, to screen for medaka genes expressed in a sex-specific fashion and for those responsive to E2, led us to choose whole-body sample preparation rather than sampling from individual tissues such as liver or gonad. We first examined the variance in mRNA expression levels between pairs of individual whole fish using microarray analysis. Nine individual samples prepared from three female and six male fish were analyzed. The average correlation coefficients among female fish and male fish, respectively, were more than 0.95, indicating that changes in mRNA expression among mature fish of the same sex are small ( Fig. 1, Table 1 ). These data also demonstrate that mRNA expression profiles obtained by microarray analysis of mature medaka maintained under standard protocols [2] are highly reproducible. The reproducibility makes it an ideal tool for evaluating medaka responses maintained in different laboratories. For example, a microarray database reflecting the physiological state of medaka raised under standard conditions could serve as the basis for GLP (Good Laboratory Practice) approval by the Japanese Ministry of the Environment. In addition, because even the E2-treated fishes showed highly reproducible gene expression in our results, it was conceivable that only a small number (e.g., 3 individuals) of medaka is sufficient for microarray analyses of a particular condition, such as hormone/toxicant exposure, temperature, water quality, etc.
Statistically significant differences between male and female mRNA expression levels were measured using 2575 OLGI sequences ( Figs. 1 and 2) . More than 2/3 (1844) of these OLGIs were highly expressed in female fish (see Supplementary Table  1 ). Among them, vitellogenin I/II and choriogenin H/L are estrogen-regulated precursor proteins. Vitellogenins are the major preyolk proteins in oviparous species, including teleost fish [21] . In response to E2, they are synthesized in the female liver, secreted into the bloodstream, and finally taken up by the developing oocytes through receptor-mediated endocytosis [21] . Choriogenins H and L, which are precursors of a major subunit of the zona radiata (the inner layer of the egg envelope), are also synthesized in liver in response to estrogen, released into blood, and then incorporated into the zona radiata in sexually matured female fish [11, 22] . The presence of mRNA for these femalespecific genes, which are not normally expressed in male fish, demonstrates one effect of the exposure of male fish to estrogenic chemicals [22, 23] . Detection of mRNA or protein expressed from these genes, especially vitellogenin, has been used extensively as a biomarker for exogenous estrogenic compounds in various fish species [22, 23] .
Other female-specific genes identified by microarray analysis include egg envelope proteins, oocyte-specific RNA binding proteins, and a transcription factor containing a basic helix-loophelix motif (see Supplementary Table 1 ). All the genes described below were highly expressed in mature female medaka (female/ male ratio >10). One basic helix-loop-helix transcription factor, factor in the germ line α (FIGα), is known to play a key regulatory role in the expression of multiple oocyte-specific genes during oocyte development [24] . Egg envelope proteins, including zona pellucida (ZP)-domain proteins that are common among vertebrates, are expressed during oocyte maturation [25] . Other factors essential for oocyte maturation have been identified in fish species (zebrafish, goldfish, and medaka). Oocyte maturation is triggered by the activation of maturation-promoting factor (MPF), consisting of cdc2 (a catalytic subunit) and cyclin B (a regulatory subunit), following stimulation by 17α,20β-dihydroxy-4-pregnen-3-one (17α,20β-DP), an endogenous maturation-inducing hormone in fish species [26, 27] . Briefly, 17α, 20β-DP stimulation triggers the unmasking of cyclin B mRNA and subsequent protein synthesis. Cyclin B binding to cdc2 and activation of cdc2 by cdk7 activates MPF [26, 27] . Another oocyte-specific gene highly expressed in female medaka, 42Sp50, was originally isolated and characterized in Xenopus laevis [28] . It is one of the protein components of a 42S ribonucleoprotein particle that is abundant in previtellogenic oocytes of X. laevis [29] . The primary function of the 42Sp50 is considered to be the long-term storage of 5S RNA and aminoacyl-tRNA for use in oogenesis and early embryogenesis [29] .
In contrast to the large number of highly expressed femalespecific OLGIs, only two OLGI sequences were highly expressed in male fish (male/female ratio >10-fold) (see Supplementary Table 2 ). One of the highly male-specific OLGIs, protamine, is an arginine-rich basic protein found in the vertebrate sperm nuclei [30] . The physiological role of protamine in medaka has been suggested to protect the ejaculated spermatozoa from disruption by low osmotic pressure [31] . Other male-specific OLGIs identified in this study did not exhibit striking differences in expression between male and female fish, nor have the functions encoded by of these male-specific sequences been well characterized.
Although microarray analyses revealed no significant differences between males and females for expression of DMY or members of the DMRT gene family (data not shown), RT-PCR results demonstrated preferential expression of DMY in males (male/female ratio ∼4-fold), along with a low level of DMY expression in females (data not shown). One possible reason for this discrepancy may lie in the probes for DMY used in the microarray design; DMY shows a high degree of sequence similarity with DMRT1. The DMY gene is located in a 250-kb Y-specific chromosomal region that contains the male-determining gene and the first sex-determining gene identified in nonmammalian vertebrates [12] . The DMRT genes also are involved in sex determination as well as differentiation in various invertebrate and vertebrate species [32] [33] [34] . The founding member, DMRT1, is implicated in male development of vertebrates with species-specific differences [35] . The sequences of DMY and DMRT1 show strong similarities, and DMY appears to originate from a duplication of an autosomal segment containing the DMRT1 region [36, 37] . In addition, although DMRT1 has been reported to exhibit high expression exclusively in the testes of fish species [38, 39] , Ohmuro-Matsuyama et al. [40] showed that DMRT1 in medaka is expressed in female ovaries as well as various male tissues, with the highest expression in testis.
Alternatively, although its function has yet to be defined, high expression of one EST [AU243616, tentative annotation; weakly similar to PIR|S39079|S390 puff C-8 protein-fungus gnat (Rhynchosciara americana), partial (8%)] in male was observed by microarray analysis (see Supplementary Table 2 ). For global expression profiling using the medaka microarray, the OLGIs listed in Supplementary Table 2 , including AU243616, might be better candidates than DMY or DMRTs for male-specific biomarkers in mature fish.
Estrogenic chemicals such as E2, synthetic estrogens, and alkylphenols may change the reproductive status of organisms by adversely affecting endocrine systems [1, 41, 42] . In medaka, exposure to endogenous steroid hormones or exogenous endocrine-disrupting chemicals causes intersex (testis-ova) or sex reversal in the gonads [17, 18, 43] . E2 has been shown to induce testis-ova in male medaka at concentrations from 50 to 250 ng/L with an incidence of 100% and to induce significant amounts of hepatic vitellogenin at more than 50 ng/L after 21 days of exposure [17] . Since the Japanese Ministry of the Environment recommends 100 ng/L of E2 as a positive control for the 21-day vitellogenin induction assay (http://www.env.go. jp/chemi/end/pdfs/emedaka_all.pdf), male medaka were similarly exposed to E2 with the exception that glass beakers were used instead of water-flow systems.
Microarray analysis of the E2-treated male medaka identified 381 E2-responsive OLGIs. Of the 242 up-regulated OLGIs in E2-treated male, 169 OLGIs were also female-specific. Of the 139 OLGI sequences that showed decreased expression in E2treated males, 91 were also significantly lower in female (Fig.  2) . These results suggest that the 260 sex-specific OLGIs responsive to E2 are likely to be regulated by endogenous E2 in medaka. In contrast, the 73 sequences induced and the 48 suppressed by E2 were not categorized as sex-specific OLGIs. Although the functions of these 121 OLGIs are not well characterized, their responsiveness to E2 may be part of a more generalized response to the toxicity of this hormone. The remaining sex-specific OLGIs were neither induced nor suppressed by E2, suggesting that the expression of these sexspecific genes may not be E2 sensitive. Results presented in our study demonstrate the possibility of using the medaka microarray to distinguish hormone-responsive genes from genes responsible for other functions, such as detoxification.
Among the female-specific OLGIs, strong E2-induced expression of vitellogenins and choriogenins was observed in microarray analysis (see Supplementary Table 3 ). Since these genes are not normally expressed in male fish, they are ideal biomarkers for male fish that have been exposed to exogenous estrogenic compounds [22, 23] . On the other hand, E2 induction of other female-specific genes, such as ZPs, cyclins B, FIGα, and 42Sp50, was not detected in this study, suggesting that E2 treatment did not activate oocyte formation in testes (testisova). These differences demonstrate that estrogenic compounds do not synchronize activation of all female-specific OLGIs.
It has been argued that elevated vitellogenin levels or induction of testis-ova may not be responsible for reproductive impairment by estrogenic compounds [17, 44] . The question then arises: Even though E2 is known to cause feminization in medaka [17, 18] , to what degree were male medaka "feminized" by the E2 treatment? Pair-wise comparisons between the expression levels of individual OLGI sequences (e.g., vitellogenins, choriogenins, and ZPs) cannot comprehensively answer this question. Therefore, to assess the degree of feminization and the degree of male dysfunction (demasculinization) using the mRNA expression profiles obtained in this study, we used Euclidean distance and the Pearson correlation coefficient (Pearson CC) [45] to compute similarity (or distance) between gene expression measures.
The Euclidean distance of a series of expression data, x = {x 1 , x 2 , …, x n }, from origin is defined as
where x is the average value in x (in this case, the mean of 22,587 OLGIs in the male, female, or E2-treated male groups).
The Pearson CC between two series of expression data, x = {x 1 , x 2 , …, x n } and y = {y 1 , y 2 , …, y n }, is defined as
(2) where θ is a vector angle between the two datasets, and x, y are the average values in x, y, respectively (in this case, the means of 22,587 OLGIs in the male, female, or E2-treated male groups). The Pearson CC can range between −1 and 1, with 1 indicating complete identity between the two series, 0 indicating no correlation, and −1 indicating negative correlations between all loci. Euclidean distance preserves the information about the magnitude of changes in the mRNA expression levels directly, whereas the Pearson CC reflects the similarity in expression patterns [45] . Thus, the Euclidean distances of the expression datasets were calculated first, and then the Pearson CC values were combined with the Euclidean distances to estimate the degree of feminization and the degree of demasculinization.
To determine the degree of feminization or dysfunction of the male, only sex-specific OLGIs were used, since other OLGIs are likely to involve physiological functions or effects common to both sexes and may lead to correlations pertaining to factors other than sex-specific functions. The average normalized expression levels for each of the 2575 sex-specific OLGIs (Fig. 2, (a)-(d) ) in males, females, and E2-treated males were used for calculations. Fig. 5 shows a vector diagram of spatial relationships between male, female, and E2-treated male derived from microarray data. The Pearson CCs, cos α, β, and γ (defined in Fig. 5 ) were calculated as 0.159, 0.677, and 0.602, respectively, and indicate only weak similarities between male and female sex-specific OLGI expression profiles. Because changes in the expression levels of individual sex-specific genes were not synchronous in response to E2, the E2-male profile was displaced from both the male and the female directions. The "feminization factor" of the E2-treated male, defined as the distance that the E2-male "moved" from male to female directions, was calculated as 0.342 ( Fig. 5 ), suggesting that E2 treatment "weakly feminized" male medaka in this study.
While trying to measure the degree of damage on male physiological function by E2 treatment, we asserted that the distance the E2-male migrated away from the male direction would represent the degree of male dysfunction. The "dysfunction factor" or "demasculinization factor" for E2 treatment of males, estimated to be 0.096 (Fig. 5) , suggested that E2 treatment did not significantly disrupt male physiological functions even though various female-specific OLGIs were dramatically induced.
It has been demonstrated that functional sex reversal in medaka can be achieved only by hormone exposure at a sensitive period of early development [7, 9, 18] . By exposing adult males to hormones, the sex of medaka cannot be functionally reversed even though the E2-responsive genes (e.g., vitellogenin) are dramatically induced [22, 23] , and the testis-ova are also observed in some cases [17, 18, 43] . In fact, no induction of genes that are related to female structures (e.g., ZPs, cyclins B, FIGα) in the E2-treated male was observed in this study. The calculated feminization/demasculinization factors for E2-treated males also strongly indicate that the E2 treatment in this study did not sexually reverse but only weakly feminized adult male medaka without disturbing male physiological functions.
To the best of our knowledge, this is the first attempt at estimating the impact of hormones using global mRNA expression profiling. We propose that the combination of Pearson CC and Euclidean distances demonstrated in this study could be used to calculate overall effects of hormones, since both the magnitude of changes in the mRNA expression levels and the changes in the expression patterns are taken into account. The magnitude of changes in mRNA expression levels, however, varies significantly, so that distance might presumably be overestimated by the influence of highly expressed mRNAs. We would emphasize that although we chose whole body preparation rather than tissue-specific analysis to establish global gene expression profiles of medaka in response to Fig. 5 . A feminization factor (left) and a male dysfunction factor (right) determined using Pearson correlation coefficients and Euclidean distances based on the expression levels of sex-specific OLGIs in each group. Vector angles α, β, and γ are indicated as the angles between male and female, male and E2-male, and E2-male and female, respectively. All numbers shown are calculated when the Euclidean distance between the origin and the female is defined as 1.0. various chemical exposures, the tissue-specific analysis would probably detect more candidates for important hormone-and gender-specific gene expressions by avoiding dilution of the tissue-specific RNA by other tissues. Therefore, tissue-specific microarray analysis of hormone-dependent gene expression and weighting genes truly responsible for sexual differentiation/ determination would be necessary to quantify accurately the degree of feminization or masculinization in medaka caused by hormonally active chemicals.
In conclusion, we have demonstrated that the medaka microarray provided highly reproducible data to evaluate the physiological state of medaka male and female and E2responsive gene expressions in the male. The microarray approach thus identified signature gene subsets indicative of differentially expressed genes in normal males and females. As the sex-specific genes possess many feminization and maledysfunction markers, we calculated feminization and maledysfunction factors of E2-exposed males. However, to apply this evaluation method to a wider range of hormonally active chemicals (such as endocrine disruptors) we should clarify the relationship between intensity of gene expression alteration and strength of hormonal activity, because E2 is one of most severe feminizing hormones and less feminizing agents might fall within the level of error for microarray analysis. It should be emphasized that although further improvements are needed in our evaluation method, the genes identified here could serve as potential novel biomarkers for future investigations of specific hormonal activities in medaka and other fish models.
Materials and methods
Test organism
Japanese medaka, O. latipes (orange-red variety or "Himedaka"), were originally purchased from Tsuchiura Goldfish Fishery (Tsuchiura, Ibaraki, Japan) and then maintained at Japan Pulp & Paper Research Institute, Inc., for several generations. The brood stock was maintained at 24 ± 1°C in UVdisinfected, dechlorinated, carbon-treated tap water with a 16 h light-8 h dark photoperiod. The fish were fed Artemia nauplii (<24 h after hatching) twice daily. Medaka selected for this study were approximately 6 months posthatch and fully mature. Growth conditions followed guidelines recommended by the International Toxicity Test Protocol [2] . For microarray analysis, female and male fish (body wt ∼400 mg; total length ∼3 cm) were collected from the brood stock, flash-frozen in liquid nitrogen, and stored at −80°C for RNA extraction.
Test chemical 17β-Estradiol was obtained from Sigma Chemical Industries, Ltd. (St. Louis, MO, USA). An E2 stock solution of 20 μg/ml was prepared by dissolving 2 mg E2 in 100 ml dimethyl sulfoxide (Wako Pure Chemical Industries, Osaka, Japan).
Exposure conditions
E2 has been reported to induce vitellogenin and testis-ova (oocyte formation in testes) in adult male medaka at a concentration of >20 ng/L [17] . Since treatment with 100 ng/L of E2 has been used as a positive control for the vitellogenin induction assay standardized by the Japanese Ministry of the Environment (http://www.env.go.jp/chemi/end/pdfs/emedaka_all.pdf), we chose 100 ng/L as the exposure concentration in the present study. Seven mature male medaka were exposed to E2 for 21 days in 3-L glass beakers containing 2 L 100 ng/L E2 in dechlorinated tap water. The test solution was renewed daily during the experimental period. The fish were fed A. nauplii (<24 h after hatching) twice a day. Residual bait and feces in the beaker were removed and the test beaker was cleaned daily. The exposure was performed in a climate chamber at 24 ± 1°C and with a 16 h:8 h light:dark photoperiod. All fish were flash-frozen in liquid nitrogen on the last day of exposure and stored at −80°C for RNA extraction.
Construction of medaka microarray
Four sets of 60-mer oligonucleotide probes for each TIGR OLGI were designed by GeneFrontier Co. (Tokyo, Japan) based on the data from OLGI, updated May 16, 2003 (release 4.0). The total number of OLGIs was 22,587, including 10,085 TCs, 12,333 singleton ESTs, and 169 singleton ETs. The medaka microarray was synthesized using the MAS (NimbleGen Systems, Inc.) developed by Singh-Gasson et al. [20] . The medaka array contained 179,972 features for 22,587 OLGIs in duplicate.
Extraction of medaka total RNA
Total RNA from whole frozen medaka was isolated using the Qiagen RNeasy Lipid Tissue Midi Kit (Qiagen, Inc., Valencia, CA, USA) following procedures recommended by the manufacturer. Briefly, each frozen medaka was ground with a mortar and pestle in liquid nitrogen, and half of the homogeneous powder was mixed vigorously with 5 ml of QIAzol lysis reagent and incubated for 5 min at room temperature. One milliliter of chloroform was then added to the homogenate, stirred for approximately 15 s, and incubated for a few minutes at room temperature. The aqueous layer separated by centrifugation was mixed thoroughly with 3 ml 70% ethanol and applied to an RNeasy midi spin column. The column was washed and total RNA was then eluted in 300 μl of RNase-free water.
Sample labeling, hybridization, and microarray analysis
Medaka total RNA was first converted to double-stranded cDNA, followed by the synthesis of biotin-labeled cRNA using in vitro transcription as described elsewhere [46, 47] . cRNA was then purified and fragmented to an average size of 50 to 200 bp. Hybridizations were performed with single cRNA derived from one biosource (one-color hybridization). Hybridization, washing, and scanning were carried out following standard procedures (NimbleGen Systems, Inc.). The expression level of each OLGI was calculated by averaging the intensities of signals from four different probes hybridized to the OLGI. The signals between each array were normalized using Robust Multichip Analysis normalization [48] [49] [50] . GeneSpring 7.0 (Agilent Technologies, CA, USA) was used for further expression analysis. OLGIs that showed statistically significant differences between females and males with or without E2 treatment were selected by an ANOVA with Student's t test (p value cutoff 0.05). To keep the frequency of false positives low, multiple testing correlation was applied using the Benjamini and Hochberg test. A post hoc test (Student-Newman-Keuls) was performed to determine specific differences between pairs of groups.
RT-PCR
Thirty OLGIs were randomly selected for RT-PCR standards based on their distribution in the microarray gene expression profile. The sequences of primers for these 30 OLGIs were the same as the microarray probe sequences except for one primer from a sequence outside the probe for both protamine and β-actin. The forward and reverse primers are listed in Table 2 . Total RNA prepared for the microarray analysis was used as template for the RT-PCR experiments. RT-PCR was performed using the StrataScript First-Strand Synthesis System (Stratagene, La Jolla, CA, USA). The cDNA solution was diluted 20 times, and 2 μl of each dilution was used for 20 μl scale PCR with TaKaRa Ex Taq HS (TaKaRa, Shiga, Japan). Each amplification reaction was resolved on a 2% agarose gel and visualized with EtBr staining. Bands were detected and quantified using the ATTO densitograph system (Lane & Spot Analyzer version 6) (ATTO Corp., Tokyo, Japan).
